|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/277 | |
| A61P 35/00 | |||
| C07C 255/29 | |||
| C07C 317/14 | |||
| C07C 317/44 | |||
| C07C 323/62 |
| (11) | Number of the document | 2817286 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13764613.9 |
| Date of filing the European patent application | 2013-03-22 | |
| (97) | Date of publication of the European application | 2014-12-31 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/AU2013/000290 |
| Date | 2013-03-22 |
| (87) | Number | WO 2013/138863 |
| Date | 2013-09-26 |
| (30) | Number | Date | Country code |
| 2012901199 | 2012-03-23 | AU |
| (72) |
MORRIS, David Lawson, AU
|
| (73) |
Pitney Pharmaceuticals Pty Limited,
Suite 39, 1 Freshwater Parade, Claremont, Western Australia 6010,
AU
|
| (54) | KINASE INHIBITORS FOR THE TREATMENT OF CANCER |
| KINASE INHIBITORS FOR THE TREATMENT OF CANCER |